Category Medicines management

The MHRA has issued CAS alerts on supply shortages of Emerade adrenaline auto-injector devices (150/300/500 microgram) – which will be unavailable for the foreseeable future. Read more here

The MHRA has issued CAS alerts on medicine supply shortages of Ranitidine and Theophylline. Ranitidine – Tablets, effervescent tablets, oral solutions and ranitidine injection are all expected to shortly be out of stock with no date for resupply until further…

Communications from the Department of Health and Social Care regarding shortages for: Reboxetine (Edronax®) – 4 mg tablets will be out of stock from w/c 2 December until w/c 16 December 2019 due to manufacturing issues. Limited supplies of parallel…

The Department of Health and Social Care has advised that the Serious Shortage Protocol for fluoxetine 30mg capsules (SSP02) is being extended to 18 December 2019. Please also note that this SSP has been changed, so pharmacists now supply fluoxetine…

See attached supply update from the Department of Health and Social Care for Seroxat (paroxetine) 20mg/10ml oral solution which will be out of stock until January 2020 due to manufacturing delays. Paroxetine tablets remain available from various suppliers. Supply Disruption…

Withdrawal of Serious Shortage Protocol for fluoxetine 10mg capsule (Ref: SSP01) You will be aware that on Thursday 3rd October Serious Shortage Protocols were implemented for fluoxetine capsules in 10mg, 30mg and 40mg strengths with an expiry date of Thursday…